stars 1 stars 2 stars 3

We are an INNOVATIVE BIOTECHNOLOGY START-UP which leverages advanced, Physics-informed Artificial Intelligence. Our core objective is the research, development, and production of anti-infective medicinal products using cutting-edge machine learning, physics-informed generative AI, and synthetic biology. Our team is developing a data-driven and model-driven platform specifically engineered for precise monoclonal antibody (mAb) design. This innovative approach aims to reduce manufacturing costs, enhance accessibility to wider populations, and broaden the applications of monoclonal antibodies in combating infectious diseases.

Website https://www.maibe.eu/
Employees 8 (5 on RocketReach)
Founded 2025
Industry Biotechnology Research

mAIbe Questions

Arianna Cocchiglia is the Co-founder and CIO of mAIbe.

5 people are employed at mAIbe.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users